Evidence map›Paper›PMID 28281896›Full record

ArticleHuman vaccines & immunotherapeutics2017

BCG and Kawasaki disease in Mexico and Japan.

Luisa Berenise Gamez-Gonzalez, Hiromichi Hamada, Beatriz Adriana Llamas-Guillen, Miguel Ruiz-Fernandez, Marco Yamazaki-Nakashimada

Open access · bronzeAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Human vaccines & immunotherapeutics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. BCG: a vaccine with multiple faces.Human vaccines & immunotherapeutics · 2020
    Review
  6. Blood Mercury Levels in Children with Kawasaki Disease and Disease Outcome.International journal of environmental research and public health · 2020
    Article
  7. Controversies in diagnosis and management of Kawasaki disease.World journal of clinical pediatrics · 2018
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Luisa Berenise Gamez-Gonzaleza Department of Allergy and Clinical Immunology , Hospital Infantil de Especialidades de Chihuahua , Chihuahua , Mexico.
Hiromichi Hamadab Department of Pediatrics , Yachiyo Medical Center, Tokyo Women's Medical University , Yachiyo , Chiba , Japan.
Beatriz Adriana Llamas-Guillenc Department of Allergy and Immunology , Hospital del Niño y Adolescente Morelense , Cuernavaca Morelos , Mexico.
Miguel Ruiz-Fernandezc Department of Allergy and Immunology , Hospital del Niño y Adolescente Morelense , Cuernavaca Morelos , Mexico.
Marco Yamazaki-Nakashimadad Department of Clinical Immunology , Instituto Nacional de Pediatría, Insurgentes Cuicuilco Coyoacan , Mexico City , Mexico.
Universidad Privada del Estado de Morelos · MXHospital de Especialidades · MXInstituto Nacional de Pediatria · MXTokyo Women's Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dr. Tomisaku Kawasaki was the first to describe BCG reactivation in Kawasaki Disease (K

Indexed as

BCG VaccineCross ReactionsFemaleHumansInfantJapanMaleMexicoMucocutaneous Lymph Node SyndromeMycobacterium bovisTuberculosis, CutaneousVaccinationBCG VaccineBCGKawasaki diseasetokyo172Tuberculid

Identifiers

PMID28281896
PMCPMC5443388
OpenAlexW2593591195

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.